Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Biopsy
Carcinoma, Non-Small-Cell Lung
Diagnosis, Differential
Early Detection of Cancer
Female
Humans
Lung Neoplasms
Male
Middle Aged
Multiple Pulmonary Nodules
Neoplasm Staging
Predictive Value of Tests
Proteomics
Retrospective Studies
Solitary Pulmonary Nodule
Spectrometry, Mass, Electrospray Ionization
Tomography, X-Ray Computed
Tumor Burden
authors with profiles
James Randolph Sanders Hocker
Megan Ross Lerner